发明名称 Polimorfos cristalinos de 1-(3-terc-butil-1-p-tolil-1h-pirazol-5-il)-3-(5-fluoro-2-(1-(2-hidroxietil)-1h-indazol-5-iloxi)bencil)urea; proceso para prepararlos; composicion farmaceutica; proceso para prepararla; y su uso para el tratamiento de un trastorno proliferativo tal como el sindrome mielodisplastico.
摘要 <p>Provided herein is a hydrogen chloride salt of 1-(3-/t?r/-butyl-1-p-tolyl-1H-pyrazol-5-yl)-3-(5-fluoro-2-(1-(2-hydroxyethyl)-1H-indazol-5-yloxy)benzyl)urea, crystalline forms of 1-(3-½̂butyl-1̂-tolyl-1H-pyrazol-5-yl)-3-(5-fluoro-2-(1-(2-hydroxyethyl)-1H-indazol-5-yloxy)benzyl)urea hydrochloride, processes for the preparation of said crystalline forms, pharmaceutical compositions containing a crystalline form of 1-(3-r<i/-r-butyl-1-p-tolyl-1H-pyrazol-5-yl)-3-(5-fluoro-2-(1-(2-hydroxyethyl)-1H-indazol-5-yloxy)benzyl)urea hydrochloride Form B, processes for the preparation of said compositions, pharmaceutical compositions prepared by said methods, and the use of said compositions in the treatment of various diseases and disorders.</p>
申请公布号 CL2014002296(A1) 申请公布日期 2014.11.07
申请号 CL20140002296 申请日期 2014.08.28
申请人 ARRAY BIOPHARMA, INC. 发明人 CORSON, DONALD T.;ARRIGO, ALISHA B.;MANNILA CORALEE G.
分类号 C07D231/56;A61K31/416;A61P7/00 主分类号 C07D231/56
代理机构 代理人
主权项
地址